학술논문

Pre-treatment immune status predicts disease control in NSCLCs treated with chemoradiation and durvalumab
Document Type
Article
Source
In: Radiotherapy and Oncology. (Radiotherapy and Oncology, February 2022, 167:158-164)
Subject
Language
English
ISSN
18790887
01678140